At Market Issuance Sales AgreementVaxart, Inc. • December 20th, 2018 • Biological products, (no disgnostic substances) • New York
Company FiledDecember 20th, 2018 Industry Jurisdiction
At Market Issuance Sales AgreementVaxart, Inc. • December 20th, 2018 • Biological products, (no disgnostic substances) • New York
Company FiledDecember 20th, 2018 Industry Jurisdiction